AirSculpt Technologies Inc

AirSculpt Technologies’ Q1 2026 earnings reveal a volatile stock amid a $179 M market cap, yet its premium, minimally invasive body‑contouring method remains a key growth promise.

AirSculpt Technologies reports FY 2025 revenue down 15.5 % and net loss per share of $0.058, citing weaker demand for body‑contouring services.

AirSculpt Technologies reported a 17.3% decline in revenue and a net loss of $2.8 million in Q1 2025, citing a decrease in case volume and a shift from profitability.